• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Calibr - Articles and news items

Bristol Myers Squibb logo

Bristol-Myers Squibb and Calibr sign worldwide agreement focused on new treatment approaches for fibrotic diseases

Industry news / 5 January 2015 / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company and the California Institute for Biomedical Research (Calibr) announced they have entered into a worldwide research collaboration to develop novel small molecule anti-fibrotic therapies, and an exclusive license agreement that allows Bristol-Myers Squibb to develop, manufacture and commercialize Calibr’s preclinical compounds resulting from the collaboration…

Peter G. Schultz

Merck and partners create the California Institute for Biomedical Research (Calibr)

Industry news, News / 19 March 2012 / Merck

Calibr presents a new paradigm for academic-industry cooperation…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +